{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T07:05:36Z","timestamp":1778483136198,"version":"3.51.4"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T00:00:00Z","timestamp":1364947200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0060040","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T03:29:53Z","timestamp":1365046193000},"page":"e60040","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":89,"title":["Full Inhibition of Spinal FAAH Leads to TRPV1-Mediated Analgesic Effects in Neuropathic Rats and Possible Lipoxygenase-Mediated Remodeling of Anandamide Metabolism"],"prefix":"10.1371","volume":"8","author":[{"given":"Katarzyna","family":"Starowicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wioletta","family":"Makuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Korostynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Malek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Slezak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Zychowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Petrosino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"De Petrocellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigia","family":"Cristino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Przewlocka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Di Marzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,4,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1098\/rstb.2011.0382","article-title":"Why do cannabinoid receptors have more than one endogenous ligand?","volume":"367","author":"V Di Marzo","year":"2012","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/22761","article-title":"Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide","volume":"400","author":"PM Zygmunt","year":"1999","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Cortright DN, Szallasi A (2009) TRP channels and pain. Curr Pharm Des 15: 1736\u201349. Review.","DOI":"10.2174\/138161209788186308"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Chung MK, Jung SJ, Oh SB (2011) Role of TRP channels in pain sensation. Adv Exp Med Biol 704: 615\u201336. Review.","DOI":"10.1007\/978-94-007-0265-3_33"},{"key":"ref5","first-page":"13","article-title":"Biochemistry and pharmacology of endovanilloids.Pharmacol Ther","volume":"114","author":"K Starowicz","year":"2007"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"13739","DOI":"10.1523\/JNEUROSCI.3258-07.2007","article-title":"Tonic endovanilloid facilitation of glutamate release in brainstem descending antinocice-ptive pathways","volume":"27","author":"K Starowicz","year":"2007","journal-title":"J Neurosci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pharmthera.2009.10.005","article-title":"The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation","volume":"125","author":"K Alawi","year":"2010","journal-title":"Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2174\/187152711796235005","article-title":"Cannabinoid 1 (CB1) receptor\u2013pharmacology, role in pain and recent developments in emerging CB1 agonists","volume":"10","author":"R Talwar","year":"2011","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.bjp.0703850","article-title":"Structure \u2013 activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens","volume":"132","author":"RA Ross","year":"2001","journal-title":"Br J Pharmacol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0959-4388(02)00340-9","article-title":"Endovanilloid signaling in pain","volume":"12","author":"V Di Marzo","year":"2002","journal-title":"Curr Opin Neurobiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1054\/plef.2001.0362","article-title":"Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy","volume":"66","author":"ASC Rice","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0014-5793(97)01603-7","article-title":"Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand","volume":"422","author":"SK Goparaju","year":"1998","journal-title":"FEBS Lett"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1021\/jm980461j","article-title":"Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase","volume":"42","author":"W Lang","year":"1999","journal-title":"J Med Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0009-3084(02)00150-0","article-title":"A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation","volume":"121","author":"TP Dinh","year":"2002","journal-title":"Chem Phys Lipids"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"23278","DOI":"10.1074\/jbc.M201084200","article-title":"15-Lipoxygenase metabolism of 2-arachidonoylglycerol. Generation of a peroxisome proliferator-activated receptor \u03b1 agonist","volume":"277","author":"KR Kozak","year":"2002","journal-title":"J Biol Chem"},{"key":"ref16","first-page":"745","article-title":"Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism.J Pharmacol Exp Ther","volume":"309","author":"I Matias","year":"2004"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1124\/mol.54.1.180","article-title":"Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation","volume":"54","author":"WS Edgemond","year":"1998","journal-title":"Mol Pharmacol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.bjp.0704223","article-title":"A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus","volume":"134","author":"SJ Craib","year":"2001","journal-title":"Br J Pharmacol"},{"key":"ref19","first-page":"2352","article-title":"Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors. J Med Chem","volume":"46","author":"G Tarzia","year":"2003"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.bcp.2005.05.011","article-title":"Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels","volume":"70","author":"E de Lago","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1124\/jpet.105.093286","article-title":"Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors","volume":"16","author":"S Maione","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuropharm.2006.08.011","article-title":"Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats","volume":"52","author":"S Petrosino","year":"2007","journal-title":"Neuropharmacology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.neuropharm.2011.11.021","article-title":"Spinal anandamide produces analgesia in neuropathic rats: possible CB(1)- and TRPV1-mediated mechanisms","volume":"62","author":"K Starowicz","year":"2012","journal-title":"Neuropharmacology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e31111","DOI":"10.1371\/journal.pone.0031111","article-title":"Discovery of prostamide f(2\u03b1) and its role in inflammatory pain and dorsal horn nociceptive neuron hyperexcitability","volume":"7","author":"L Gatta","year":"2012","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/mol.59.1.9","article-title":"Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist","volume":"59","author":"P Wahl","year":"2001","journal-title":"Mol Pharmacol"},{"key":"ref26","first-page":"1045","article-title":"Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Mol. Pharmacol","volume":"57","author":"W Gonsiorek","year":"2000"},{"key":"ref27","first-page":"605","article-title":"Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J. Biol. Chem","volume":"275","author":"T Sugiura","year":"2000"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neuroscience.2011.12.028","article-title":"Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury","volume":"203","author":"PW Brownjohn","year":"2012","journal-title":"Neuroscience"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/sj.bjp.0705467","article-title":"Anandamide and vanilloid TRPV1 receptors","volume":"140","author":"RA Ross","year":"2003","journal-title":"Br J Pharmacol"},{"key":"ref30","first-page":"38496","article-title":"Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists","volume":"Chem280","author":"P Movahed","year":"2005","journal-title":"J Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/138161208783330790","article-title":"TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications","volume":"14","author":"K Starowicz","year":"2008","journal-title":"Curr Pharm Des"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.tips.2008.03.001","article-title":"FAAH and anandamide: is 2-AG really the odd one out?","volume":"29","author":"V Di Marzo","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"ref33","first-page":"902","article-title":"Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain. J. Pharmacol. Exp. Ther","volume":"330","author":"SG Kinsey","year":"2009"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jpain.2010.04.001","article-title":"Fatty acid amide hydrolase and monoacylglycerol lipase inhibitors produce anti-allodynic effects in mice through distinct cannabinoid receptor mechanisms","volume":"11","author":"SG Kinsey","year":"2010","journal-title":"J Pain"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pain.2007.03.008","article-title":"Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain","volume":"133","author":"M Suard\u00edaz","year":"2007","journal-title":"Pain"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1113\/jphysiol.2004.081844","article-title":"Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1","volume":"564","author":"X Wang","year":"2005","journal-title":"J Physiol"},{"key":"ref37","first-page":"21","article-title":"Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals.Vet J","volume":"173","author":"G Re","year":"2007"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.pain.2008.06.003","article-title":"The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors","volume":"139","author":"B Costa","year":"2008","journal-title":"Pain"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"12856","DOI":"10.1074\/jbc.M008555200","article-title":"The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism","volume":"276","author":"L De Petrocellis","year":"2001","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/bph.12029","article-title":"Activation and Desensitization of Trpv1 Channels in Sensory Neurons by the Peroxisome Proliferator-Activated Receptor \u03b1 Agonist Palmitoylethanolamide","volume":"168","author":"P Ambrosino","year":"2013","journal-title":"Br J Pharmacol"},{"key":"ref41","first-page":"21","article-title":"Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals. Vet. J","volume":"173","author":"G Re","year":"2007"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Di Marzo V (2006) Endocannabinoids: synthesis and degradation. In: Amara SG, Bamberg E, Fleischmann BK, Gudermann TH, Hebert SC, <etal>et al<\/etal>.., editors. Review of Physiology Biochemistry and Pharmacology. Berlin: Springer. 1\u201324.","DOI":"10.1007\/112_0505"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pharmthera.2008.08.001","article-title":"The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products","volume":"120","author":"DF Woodward","year":"2008","journal-title":"Pharmacol Ther"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1523\/JNEUROSCI.23-10-04127.2003","article-title":"Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases","volume":"23","author":"WB Veldhuis","year":"2003","journal-title":"J Neurosci"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"23278","DOI":"10.1074\/jbc.M201084200","article-title":"15-Lipoxygenase metabolism of 2-arachidonoylglycerol. Generation of a peroxisome proliferator-activated receptor \u03b1 agonist","volume":"277","author":"KR Kozak","year":"2002","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s11745-012-3684-z","article-title":"Metabolism of anandamide into eoxamides by 15-lipoxygenase-1 and glutathione transferases","volume":"47","author":"PK Forsell","year":"2012","journal-title":"Lipids"},{"key":"ref47","first-page":"378","article-title":"Methylation and acetylation of 15-hydroxyanandamide modulate its interaction with the endocannabinoid system.Biochimie","volume":"92","author":"D Amadio","year":"2010"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1073\/pnas.1118477109","article-title":"15-Lipoxygenase eicosanoids are the putative ligands for vanilloid receptors and peroxisome proliferator-activated receptors (PPARs)","volume":"109","author":"U Mabalirajan","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref49","first-page":"645","article-title":"Is 15-LOX-1 a tumor suppressor? J Natl Cancer Inst","volume":"104","author":"A Umar","year":"2012"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"M Zimmermann","year":"1983","journal-title":"Pain"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0031-9384(76)90029-9","article-title":"Chronic catheterization of the spinal subarachnoid space","volume":"17","author":"TL Yaksh","year":"1976","journal-title":"Physiol Behav"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"1","author":"GJ Bennett","year":"1988","journal-title":"Pain"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"K Hargreaves","year":"1988","journal-title":"Pain"},{"key":"ref54","first-page":"671","article-title":"Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells.Biochem J","volume":"322","author":"T Bisogno","year":"1997"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0060040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T21:23:48Z","timestamp":1595625828000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0060040"}},"subtitle":[],"editor":[{"given":"Bernard","family":"Le Foll","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,3]]},"references-count":54,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0060040","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,3]]}}}